Transdermal 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-l in postmenopausal women
- 1 July 1992
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 15 (7) , 533-538
- https://doi.org/10.1007/bf03348801
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarctionAtherosclerosis, 1989
- COMPARISON OF THE EFFECTS OF ORAL AND TRANSDERMAL OESTRADIOL ADMINISTRATION ON OESTROGEN METABOLISM, PROTEIN SYNTHESIS, GONADOTROPHIN RELEASE, BONE TURNOVER AND CLIMACTERIC SYMPTOMS IN POSTMENOPAUSAL WOMENClinical Endocrinology, 1989
- Estradiol stimulates invitro the secretion of insulin-like growth factors by the clonal osteoblastic cell line, UMR106Biochemical and Biophysical Research Communications, 1989
- Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogenMaturitas, 1988
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- A Preliminary Study of the Effect of Estrogen Dose on Growth in Turner's SyndromeNew England Journal of Medicine, 1983
- The ageing muscleClinical Physiology and Functional Imaging, 1983
- A prospective study of change in bone mass with age in postmenopausal womenJournal of Chronic Diseases, 1982
- Estradiol treatment of acromegaly Reduction of immunoreactive somatomedin-C and improvement in metabolic statusThe American Journal of Medicine, 1980